N-(2-Methyl-4-oxopentan-2-yl)acrylamide, 95.0%, 1kg

3-Bromo-4-fluoroaniline hydrochloride, 95.0%, 5g

Benzaldéhyde, min 99,5 %, pour la synthèse, 500 ml, emballage en verre

5-Methyl-3-(2',6'-dichlorophenyl)-4-isoxazolecarboxylic acid, 98.0%, 10g

2-Chloro-6-(difluoromethyl)pyridine, 97.0%, 1g

1H,1H,2H,2H-Perfluoro-1,6-hexyldimethacrylate, 1g

(S)-Methyl 2-((tert-butoxycarbonyl)amino)-3-iodopropanoate, 97.0%, 10g

1,8-Naphthyridine-3-carboxylic acid, 95.0%, 1g

4-Chloro-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine, 95.0%, 5g

3,3-bis(methylsulfanyl)-1-phenylprop-2-en-1-one, 95.0%, 500mg

(2S,5S)-(-)-5-BENZYL-3-METHYL-2-(5-METHYL-2-FURYL)-4-IMIDAZOLIDINONE, 95%, 1g

(R)-2-Hydroxy-2-(p-tolyl)acetic acid, 97%, 1g

2-ETHENYL-6-METHYLPYRAZINE, 95%, 100mg